Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxidative medicine and cellular longevity. 2013;2013.
Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns. 2008;34(1):6-17.
Horton JW. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology. 2003;189(1):75-88.
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The international journal of biochemistry & cell biology. 2007;39(1):44-84.
Ghaffari T, Nouri M, Irannejad E, Rashidi M-R. Effect of vitamin E and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats. BioImpacts: BI. 2011;1(2):121.
Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. Journal of Clinical Investigation. 1998;101(8):1581.
Mackness MI, Arrol S, Mackness B, Durrington PN. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. The Lancet. 1997;349(9055):851-2.
Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN. Serum paraoxonase after myocardial infarction. Arteriosclerosis, thrombosis, and vascular biology. 1999;19(2):330-5.
Akcay M, Yilmaz I, Polat M, Akcay G. Serum paraoxonase levels in gastric cancer. Hepato-gastroenterology. 2003;50:cclxxiii-cclxxv.
Stevens VL, Rodriguez C, Talbot JT, Pavluck AL, Thun MJ, Calle EE. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS‐II Nutrition Cohort. The Prostate. 2008;68(12):1336-40.
Demirdöğen BC, Türkanoğlu A, Bek S, et al. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clinical biochemistry. 2008;41(1):1-9.
Pandey R, Singh M, Singhal U, Gupta KB, Aggarwal SK. Oxidative/nitrosative stress and the pathobiology of chronic obstructive pulmonary disease. Journal of clinical and diagnostic research: JCDR. 2013;7(3):580.
Yildirim S, Doganay S, Yildirim A, Aydin OE, Karakoc A, Laloglu E. Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury. The Eurasian Journal of Medicine. 2012;44(3):153.
Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biology and Medicine. 1999;26(7):892-904.
Sanghera DK, Saha N, Kamboh MI. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese. Atherosclerosis. 1998;136(2):217-23.
Yamada Y, Ando F, Niino N, Miki T, Shimokata H. Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. Journal of human genetics. 2003;48(9):469-75.
Chen J, Kumar M, Chan W, Berkowitz G, Wetmur JG. Increased influence of genetic variation on PON1 activity in neonates. Environmental Health Perspectives. 2003;111(11):1403.
Alejandra Aguayo-Becerra O, Torres-Garibay C, Dassaejv Macias-Amezcua M, et al. Serum albumin level as a risk factor for mortality in burn patients. Clinics. 2013;68(7):940-5.
James RW, Deakin SP. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radical Biology and Medicine. 2004;37(12):1986-94.
Razavi AE, Ani M, Pourfarzam M, Naderi GA. Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2012;17(11):1020.
Schiavon R, Battaglia P, De Fanti E, et al. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism. Clinica chimica acta. 2002;324(1):39-44.
Kelso GJ, Stuart WD, Richter RJ, Furlong CE, Jordan-Starck TC, Harmony JA. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry. 1994;33(3):832-9.
Mackness B, Durrington P, Boulton A, Hine D, Mackness M. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. European journal of clinical investigation. 2002;32(4):259-64.
Van Lenten BJ, Navab M, Shih D, Fogelman AM, Lusis AJ. The role of high-density lipoproteins in oxidation and inflammation. Trends in cardiovascular medicine. 2001;11(3):155-61.